4//SEC Filing
Stephens Kristin 4
Accession 0001209191-23-054168
CIK 0001556263other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:52 PM ET
Size
9.2 KB
Accession
0001209191-23-054168
Insider Transaction Report
Form 4
Stephens Kristin
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2023-10-31+17,000→ 21,465 total - Exercise/Conversion
Restricted Stock Units
2023-10-31−17,000→ 17,000 total→ Common Stock (17,000 underlying) - Tax Payment
Common Stock
2023-11-01$2.22/sh−5,676$12,601→ 15,789 total
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares used to cover tax withholding on a restricted stock unit release.
- [F3]Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]Represents a restricted stock unit award granted on October 6, 2022. These restricted stock units vested as to one half (50%) of the shares on October 31, 2023, and are scheduled to vest as to one half (50%) of the shares on October 31, 2024.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001865490
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:52 PM ET
- Size
- 9.2 KB